Henry Schein, Inc. $HSIC Shares Sold by Artisan Partners Limited Partnership

Artisan Partners Limited Partnership reduced its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 6,647,378 shares of the company’s stock after selling 185,663 shares during the quarter. Artisan Partners Limited Partnership owned approximately 0.06% of Henry Schein worth $502,409,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC acquired a new position in Henry Schein during the 2nd quarter valued at about $25,000. MUFG Securities EMEA plc acquired a new position in Henry Schein during the 2nd quarter valued at about $27,000. Flagship Harbor Advisors LLC acquired a new position in Henry Schein during the 4th quarter valued at about $30,000. Federated Hermes Inc. acquired a new position in Henry Schein during the 4th quarter valued at about $32,000. Finally, Los Angeles Capital Management LLC acquired a new position in Henry Schein during the 4th quarter valued at about $37,000. 96.62% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HSIC has been the topic of several research analyst reports. Citigroup initiated coverage on Henry Schein in a research note on Wednesday, April 15th. They set a “buy” rating and a $100.00 price target on the stock. Wells Fargo & Company boosted their price target on Henry Schein from $76.00 to $87.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 25th. Robert W. Baird set a $97.00 price target on Henry Schein in a research note on Wednesday, May 6th. Mizuho dropped their price target on Henry Schein from $88.00 to $82.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Finally, Leerink Partners reiterated a “market perform” rating on shares of Henry Schein in a research note on Monday, March 9th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $87.85.

Henry Schein Stock Up 0.1%

Henry Schein stock opened at $81.21 on Wednesday. The firm has a market cap of $9.25 billion, a price-to-earnings ratio of 24.53, a price-to-earnings-growth ratio of 1.56 and a beta of 0.82. Henry Schein, Inc. has a 52 week low of $61.94 and a 52 week high of $89.29. The business’s 50-day moving average price is $75.65 and its 200 day moving average price is $76.31. The company has a quick ratio of 0.75, a current ratio of 1.36 and a debt-to-equity ratio of 0.59.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, May 5th. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.20 by $0.12. The firm had revenue of $3.37 billion for the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.Henry Schein’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $1.15 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 5.32 earnings per share for the current year.

Insider Activity

In related news, Director William K. Daniel bought 10,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average cost of $69.19 per share, with a total value of $691,900.00. Following the completion of the acquisition, the director directly owned 20,000 shares in the company, valued at approximately $1,383,800. The trade was a 100.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Thomas C. Popeck sold 1,355 shares of the firm’s stock in a transaction dated Thursday, March 19th. The stock was sold at an average price of $72.79, for a total value of $98,630.45. Following the sale, the chief executive officer directly owned 86,182 shares in the company, valued at approximately $6,273,187.78. This trade represents a 1.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.89% of the stock is owned by company insiders.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.